Skip to main content
. 2026 Feb 22;15(2):232. doi: 10.3390/antibiotics15020232
ICUs Intensive Care Units;
HAP Hospital-Acquired Pneumonia;
VAP Ventilator-Associated Pneumonia;
CAP Community-acquired pneumonia;
LOS Length of Stay;
LRTIs Lower Respiratory Tract Infections;
RTIs Respiratory Tract Infections;
MDR Multidrug-resistant;
AMR Antimicrobial Resistance;
APACHE II Acute Physiology and Chronic Health Evaluation II;
SOFA Sequential Organ Failure Assessment;
SOFA-2 Sequential Organ Failure Assessment 2;
NLR Neutrophil-to-Lymphocyte Ratio;
PLR Platelet-to-Lymphocyte Ratio;
BMI Body Mass Index;
CRP C-reactive protein;
EUCAST European Committee on Antimicrobial Susceptibility Testing;
MRSA Methicillin-resistant Staphylococcus aureus;
MSSA Methicillin-susceptible Staphylococcus aureus;
XDR Extensively drug-resistant;
PDR Pandrug-resistant;
AKI Acute kidney injury;
SA-AKI Sepsis-associated acute kidney injury;
MODS Multiple Organ Dysfunction Syndrome;
ARDS Acute Respiratory Distress Syndrome;
COPD Chronic Obstructive Pulmonary Disease;
CPIS Clinical Pulmonary Infection Score;
CRE Carbapenem-resistant Enterobacterales